يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"Starck-Schwertz, S."', وقت الاستعلام: 0.98s تنقيح النتائج
  1. 1
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  3. 3
    Understanding the Molecular Pathogenesis of and Response to Canakinumab Treatment in TNF Receptor-Associated Periodic Syndrome By Gene Expression Profiling of Whole Blood from Patients

    المؤلفون: Nirmala, N., Abrams, K., Hartmann, N., Letzkus, M., Starck-Schwertz, S., Affentranger, U., Baeriswyl, L., Caorsi, R., Tormey, V., Meini, A., Laura Piera OBICI, Lachmann, H., Gattorno, M., Torene, R.

    المصدر: Publons

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::754d708bd9a1599647ce7ad54a6c4337
    https://publons.com/publon/27317078/

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Gene expression profiling of immunomagnetically separated cells directly from stabilized whole blood for multicenter clinical trials.

    المؤلفون: Letzkus M; Biomarker Development, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Luesink E; Biomarker Development, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Starck-Schwertz S; Biomarker Development, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Bigaud M; Biomarker Development, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Mirza F; Scientific Capability Development, Pharma-Development, Novartis Pharma AG, Basel, Switzerland., Hartmann N; Biomarker Development, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Gerstmayer B; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany., Janssen U; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany., Scherer A; Spheromics, Kontiolahti, Finland., Schumacher MM; Biomarker Development, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Verles A; Biomarker Development, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Vitaliti A; Biomarker Development, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Nirmala N; Biomarker Development, Novartis Institutes for BioMedical Research (NIBR), Cambridge, MA, USA., Johnson KJ; Biomarker Development, Novartis Institutes for BioMedical Research (NIBR), Cambridge, MA, USA., Staedtler F; Biomarker Development, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland.

    المصدر: Clinical and translational medicine [Clin Transl Med] 2014 Nov 13; Vol. 3, pp. 36. Date of Electronic Publication: 2014 Nov 13 (Print Publication: 2014).

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: eCollection Cited Medium: Print ISSN: 2001-1326 (Print) Linking ISSN: 20011326 NLM ISO Abbreviation: Clin Transl Med Subsets: PubMed not MEDLINE

    Find this article in full text from Springer Verlag. View record at Wiley Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء